NORMAL SITUATION

Etudes cliniques-Cliniques du Sud-Luxembourg-Médecine Interne

Company — Normal situation.

Financial year 2022 · Closed on 31/12/2022

Net result-357 €-199,1 %over 1 year
Gross margin-324,2 €-178,1 %over 1 year

Identity

Source · BCE/KBO

Etudes cliniques-Cliniques du Sud-Luxembourg-Médecine Interne is a company registered in Belgium.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0834.829.411
Legal form
Economic interest grouping with a registered office in Belgium
Latest accounts
31/12/2022

Financials

Source · NBB, 12 filings

Trend over 12 financial years

20222021202020192018
Income statement
Gross margin-324,2 €415,1 €14,6 k €22 k €37,9 k €
EBITDA-324,2 €415,1 €14,6 k €22 k €37,9 k €
Operating result-324,2 €415,1 €14,6 k €22 k €37,9 k €
Net result-357 €360,1 €14,6 k €22 k €37,9 k €
Balance sheet
Total assets6,3 k €7,9 k €7,4 k €31,3 k €13,9 k €
Cash6,1 k €6,1 k €5,6 k €27,6 k €9,4 k €
Debts6,3 k €7,9 k €7,4 k €31,3 k €13,9 k €

Board of directors

Source · NBB, accounts to 31/12/2022

1 active · 1 ended

Active mandates

DirectorMandates in this companyPeriod
WEYNANTS HEMATOLOGIE0655.683.178
Director10/06/2021 → 04/06/2026

Ended mandates

DirectorMandates in this companyPeriod
EMONTS MICHEL, Cardiologue0463.542.313Represented by Michel EMONTS
Manager

Full financial information

Source · NBB
202220212020201920182017
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202201/01/202101/01/202001/01/201901/01/201801/01/2017
Closing of the financial year31/12/202231/12/202131/12/202031/12/201931/12/201831/12/2017
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date14/07/202320/07/202230/09/202105/10/202030/08/201914/06/2018
General meeting22/06/202309/06/202229/09/202124/09/202006/06/201907/06/2018
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 12 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202222/06/202314/07/2023FrenchPDF
Micro model31/12/202109/06/202220/07/2022FrenchPDF
Micro model31/12/202029/09/202130/09/2021FrenchPDF
Micro model31/12/201924/09/202005/10/2020FrenchPDF
Micro model31/12/201806/06/201930/08/2019FrenchPDF
Micro model31/12/201707/06/201814/06/2018FrenchPDF
Micro model31/12/201601/06/201722/08/2017FrenchPDF
Abridged model31/12/201502/06/201623/08/2016FrenchPDF
Abridged model31/12/201404/06/201507/07/2015FrenchPDF
Abridged model31/12/201305/06/201423/09/2014FrenchPDF
Abridged model31/12/201206/06/201324/06/2013FrenchPDF
Abridged model31/12/201107/06/201202/07/2012FrenchPDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2022

1 active · 1 ended

Active mandates

DirectorMandates in this companyPeriod
WEYNANTS HEMATOLOGIE0655.683.178
Director10/06/2021 → 04/06/2026

Ended mandates

DirectorMandates in this companyPeriod
EMONTS MICHEL, Cardiologue0463.542.313Represented by Michel EMONTS
Manager

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Dissolution31/08/2023
    Dissolution + clôture de liquidation
    PDF
  • Mandates04/03/2022
    SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates31/12/2020
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates19/07/2017
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates16/09/2016
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates18/07/2012
    DEMISSIONS, NOMINATIONS
    PDF
  • Other06/04/2011
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Name
Registered office
Annual accounts
Filings12 filings
Mandates
WEYNANTS HEMATOLOGIE
2011201220132014201520162017201820192020202120222023202420252026
rue des Déportés 137, 6700 Arlon
Director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
rue des Déportés 137, 6700 Arlon
accounts 2021 → 2022
Accounts 2022 · 2023-00234924

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
Etudes cliniques-Cliniques du Sud-Luxembourg-Médecine Interne
accounts 2022
Accounts 2022 · 2023-00234924
Etudes cliniques-Cliniques du Sud-Luxembourg-Médecine Interne. En abrégé, Etudes cliniques-CSL-MI
accounts 2021
Accounts 2021 · 2022-20202774

Events

  1. 2022
    Annual accounts 2022-357 €↓
  2. 2022
    Name changeEtudes cliniques-Cliniques du Sud-Luxembourg-Médecine Interne
  3. 2021
    Annual accounts 2021360,1 €↓
  4. 2020
    Annual accounts 202014,6 k €↓
  5. 2019
    Annual accounts 201922 k €↓
  6. 2018
    Annual accounts 201837,9 k €↓
  7. 2017
    Annual accounts 201744,1 k €↓
  8. 2016
    Annual accounts 201665,6 k €↓
  9. 2015
    Annual accounts 201571,5 k €↑
  10. 2014
    Annual accounts 201470,4 k €↑
  11. 2013
    Annual accounts 201324,1 k €↑
  12. 2012
    Annual accounts 201215 k €↓
  13. 2011
    Annual accounts 201161,8 k €